![Iqbal S. Grewal](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Iqbal S. Grewal
No más puestos en curso
Historial de carrera de Iqbal S. Grewal
Antiguos cargos conocidos de Iqbal S. Grewal.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SEAGEN INC. | Corporate Officer/Principal | 04/06/2009 | - |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/05/1998 | - |
Formación de Iqbal S. Grewal.
University of California, Los Angeles | Doctorate Degree |
University of Aberdeen | Graduate Degree |
Panjab University Chandigarh | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Reino Unido | 2 |
India | 2 |
Operativa
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Graduate Degree | 1 |
Sectorial
Consumer Services | 4 |
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Seagen Inc.
![]() Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Iqbal S. Grewal
- Experiencia